Detalles de la búsqueda
1.
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
Int J Cancer
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721724
2.
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients.
Haematologica
; 108(12): 3308-3320, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381752
3.
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma.
Eur J Nucl Med Mol Imaging
; 50(12): 3697-3708, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37493665
4.
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
BMC Cancer
; 23(1): 1132, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990162
5.
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.
Hematol Oncol
; 41(3): 453-462, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680428
6.
(Smoldering) multiple myeloma: mismatch between tumor load estimated from bone marrow biopsy at iliac crest and tumor load shown by MRI.
Skeletal Radiol
; 52(12): 2513-2518, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300710
7.
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.
Transfus Med Hemother
; 50(5): 382-395, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899996
8.
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.
Transfus Med Hemother
; 50(5): 371-381, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936633
9.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899991
10.
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage.
Br J Haematol
; 199(1): 65-75, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608264
11.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166376
12.
Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients.
Transfus Med Hemother
; 48(2): 91-98, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33976609
13.
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(9): 1589-1596, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32428735
14.
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.
BMC Cancer
; 20(1): 353, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334570
15.
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.
BMC Cancer
; 17(1): 151, 2017 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28228122
16.
Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma.
Haematologica
; 104(9): e420-e423, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765474
17.
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma.
J Clin Apher
; 29(6): 299-304, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24771277
18.
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany.
Bone Marrow Transplant
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480852
19.
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma.
Front Oncol
; 13: 1168120, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182183
20.
Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation.
Transplant Cell Ther
; 29(10): 609.e1-609.e6, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348705